Search All News
A combination of a diabetes drug and a PI3K inhibitor may have potential in preventing melanoma from spreading to the liver, according to a study from Columbia cancer researchers.
A study from Columbia cancer researchers suggests drugs targeting the SMARCAL1 protein could strike a double blow against many cancers and make immunotherapy even more effective.
A working group of international experts, including Columbia's Mary Beth Terry, evaluated the current evidence around limiting or stopping alcohol use and lowering the risk of certain types of cancer.
- November 9, 2020
Columbia researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.
- November 5, 2020
Immunotherapy, often ineffective against stomach cancer, was more effective when combined with chemotherapy and given earlier, finds a new study in mice.
- October 29, 2020
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
- October 22, 2020
Columbia's Eileen Connolly explains how radiation treatment for breast cancer has vastly improved in recent years due to advancements in technology and an increased understanding of the disease.
- September 25, 2020
Velocity, Columbia’s annual fundraiser for cancer research, has changed this year, with participants cycling, running, and even sailing to support cancer research and care.
- August 26, 2020
The Herbert Irving Comprehensive Cancer Center has been redesignated as a Comprehensive Cancer Center by the NCI, the federal government’s principal agency for cancer research, care, and training.
- August 20, 2020
A study of cancer patients with COVID-19 finds mortality is significantly higher than in the general population and Black patients are half as likely to receive the antiviral remdesivir.